TBPH - Theravance Biopharma, Inc.

QQQ $ 629.16 $ 3.02 (0.48 %)

DIA $ 475.58 $ 0.66 (0.14 %)

SPY $ 681.80 $ 2.23 (0.33 %)

TLT $ 90.21 $ -0.27 (-0.3 %)

GLD $ 368.20 $ -2.01 (-0.54 %)

Previous Close

$ 14.66

Open

$ 14.31

Bid

$ 13.80 x 1,000

Ask

$ 14.79 x 601

Day's Range

$ 14.11 - $ 14.70

52 Week Range

$ 7.90 - $ 15.15

Volume

393,268

Average Volume

Market Cap

738.3M

Beta (5Y Monthly)

$ 0.57

PE Ratio (TTM)

$ 56.66

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-13-2025	06-30-2025	10-Q
2	05-12-2025	03-31-2025	10-Q
3	03-07-2025	01-01-1970	10-K
4	11-14-2024	09-30-2024	10-Q
5	08-08-2024	06-30-2024	10-Q
6	05-15-2024	03-31-2024	10-Q
7	03-01-2024	12-31-2023	10-K
8	11-09-2023	09-30-2023	10-Q
9	08-09-2023	06-30-2023	10-Q
10	05-10-2023	03-31-2023	10-Q
11	03-01-2023	12-31-2022	10-K
12	11-09-2022	09-30-2022	10-Q
13	08-08-2022	06-30-2022	10-Q
14	05-06-2022	03-31-2022	10-Q
15	02-28-2022	12-31-2021	10-K
16	11-08-2021	09-30-2021	10-Q
17	08-05-2021	06-30-2021	10-Q
18	05-06-2021	03-31-2021	10-Q
19	02-26-2021	12-31-2020	10-K
20	11-09-2020	09-30-2020	10-Q
21	08-10-2020	06-30-2020	10-Q
22	05-08-2020	03-31-2020	10-Q
23	02-27-2020	12-31-2019	10-K
24	11-08-2019	09-30-2019	10-Q
25	08-05-2019	06-30-2019	10-Q
26	05-10-2019	03-31-2019	10-Q
27	02-28-2019	12-31-2018	10-K
28	11-08-2018	09-30-2018	10-Q
29	08-02-2018	06-30-2018	10-Q
30	05-09-2018	03-31-2018	10-Q
31	02-28-2018	12-31-2017	10-K
32	11-08-2017	09-30-2017	10-Q
33	08-09-2017	06-30-2017	10-Q
34	05-10-2017	03-31-2017	10-Q
35	03-01-2017	12-31-2016	10-K
36	11-09-2016	09-30-2016	10-Q
37	08-09-2016	06-30-2016	10-Q
38	05-10-2016	03-31-2016	10-Q
39	03-11-2016	12-31-2015	10-K
40	11-12-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Theravance Biopharma To Present Ampreloxet...
10/29/2025 10:14:42

paccar-posts-downbeat-earnings-joins-neuphoria-therapeutics-citius-pharmaceuticals-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session

PACCAR Posts Downbeat Earnings, Joins Neup...
10/21/2025 12:16:10

why-crown-holdings-shares-are-trading-higher-by-around-9-here-are-20-stocks-moving-premarket

Why Crown Holdings Shares Are Trading High...
10/21/2025 09:46:14

Theravance Biopharma Will Be Presenting At...
10/14/2025 10:05:49

A retrospective cohort study of claims data demonstrated that following hospital discharge, patients adherent to YUPELRI experi...

this-protagonist-therapeutics-analyst-begins-coverage-on-a-bullish-note-here-are-top-3-initiations-for-friday

This Protagonist Therapeutics Analyst Begi...
09/12/2025 12:37:17

B. Riley Securities Initiates Coverage On ...
09/12/2025 09:33:16

B. Riley Securities analyst Mayank Mamtani initiates coverage on Theravance Biopharma (NASDAQ:TBPH) with a Buy rating and an...

Theravance Biopharma Completes Enrollment ...
08/25/2025 10:05:40

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ:TBPH), today announced completion ...

Theravance and Mylan Entered Settlement Ag...
08/20/2025 10:20:24

Theravance Biopharma Q2 Adj. EPS $(0.08) B...
08/12/2025 20:10:32

Theravance Biopharma (NASDAQ:TBPH) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of ...

Earnings Scheduled For August 12, 2025
08/12/2025 08:32:28

BTIG Maintains Buy on Theravance Biopharma...
06/27/2025 14:58:40

BTIG analyst Julian Harrison maintains Theravance Biopharma (NASDAQ:TBPH) with a Buy and raises the price target from $24 to...

Theravance Biopharma Scores $7.5M Mileston...
06/26/2025 10:02:56

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ:TBPH) today announced that Viatris...

This Coinbase Global Analyst Begins Covera...
06/17/2025 13:24:58

Jones Trading Initiates Coverage On Therav...
06/17/2025 11:10:14

Jones Trading analyst Debanjana Chatterjee initiates coverage on Theravance Biopharma (NASDAQ:TBPH) with a Buy rating and an...

Theravance, Mylan Reach Settlement With Eu...
06/06/2025 10:08:54

Theravance Biopharma Presents Analyses Of ...
05/09/2025 16:03:43

Theravance Biopharma, Inc. ("Theravance Biopharma" or the "Company") (NASDAQ:TBPH) today announced presentation...

Theravance Biopharma Q1 EPS $(0.27) Misses...
05/08/2025 20:09:46

Theravance Biopharma (NASDAQ:TBPH) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate o...

Earnings Scheduled For May 8, 2025
05/08/2025 08:33:13

Theravance To Present New Analyses Of Init...
03/27/2025 10:06:25

Results from these initial studies led to the initiation of a Phase 3 confirmatory study (CYPRESS Study 197) addressing nOH in ...

HC Wainwright & Co. Reiterates Buy on Ther...
02/27/2025 14:12:13

HC Wainwright & Co. analyst Douglas Tsao reiterates Theravance Biopharma (NASDAQ:TBPH) with a Buy and maintains $15 pric...